Clinical trial
Apixaban in Patients With Left Ventricular Thrombus Post Myocardial Infarction; A Randomized Clinical Trial
NCT05208398 is registered in ClinicalTrials.gov with Saud Al Babtain Cardiac Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apixaban in Patients With Left Ventricular Thrombus Post Myocardial Infarction; A Randomized Clinical Trial
- Lead sponsor
- Saud Al Babtain Cardiac Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 18, 2018
- Completion date
- September 30, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
left ventricular thrombus